Compound mutations in CML—imaginary bogeyman or real arch-nemesis?

Research output: Contribution to journalEditorial

LanguageEnglish
Pages102-104
Number of pages3
JournalLeukemia Research
Volume81
DOIs
Publication statusPublished - 1 Jun 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

@article{2a29cebc46e946269ca8bfb0decce394,
title = "Compound mutations in CML—imaginary bogeyman or real arch-nemesis?",
author = "David Yeung",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.leukres.2019.01.011",
language = "English",
volume = "81",
pages = "102--104",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",

}

Compound mutations in CML—imaginary bogeyman or real arch-nemesis? / Yeung, David.

In: Leukemia Research, Vol. 81, 01.06.2019, p. 102-104.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Compound mutations in CML—imaginary bogeyman or real arch-nemesis?

AU - Yeung, David

PY - 2019/6/1

Y1 - 2019/6/1

UR - http://www.scopus.com/inward/record.url?scp=85064039823&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2019.01.011

DO - 10.1016/j.leukres.2019.01.011

M3 - Editorial

VL - 81

SP - 102

EP - 104

JO - Leukemia Research

T2 - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

ER -